Obesity in early adulthood as a risk factor for psoriatic arthritis

Archives of Dermatology

Volumn 146, Issue 7, 2010, Pages 721-726

  Soltani Arabshahi, Razieh ^a   Wong, Bob ^a   Feng, Bing Jian ^a   Goldgar, David E ^a   Callis Duffin, Kristina ^a   Krueger, Gerald G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADULT; ADULTHOOD; ARTICLE; BODY MASS; BODY SURFACE; CASE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY INTERVENTION; FAMILY HISTORY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL; OBESITY; ONSET AGE; PHYSICIAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; ADOLESCENT; AGE; ARTHRITIS, PSORIATIC; COMPARATIVE STUDY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; INCIDENCE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ARTHRITIS, PSORIATIC; BODY MASS INDEX; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; UTAH; YOUNG ADULT;

EID: 77954826052     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.141     Document Type: Article

References (35)

1. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982-986.
2. Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol. 2005;125(1):61-67.
3. Cohen AD, Gilutz H, Henkin Y, et al. Psoriasis and the metabolic syndrome. Acta Derm Venereol. 2007;87(6):506-509.
4. Cohen AD, Sherf M, Vidavsky L, Vardy D, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome: a cross-sectional study. Dermatology. 2008;216(2):152-155. (Pubitemid 351158580)
5. Huerta C, Rivero E, Rodríguez L. Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007;143(12):1559-1565.
6. Sterry W, Strober B, Menter A; International Psoriasis Council. Obesity in psoriasis: the metabolic, clinical and therapeutic implications: report of an interdisciplinary conference and review. Br J Dermatol. 2007;157(4):649-655. (Pubitemid 47389868)
7. Marino MG, Carboni I, De Felice C, Maurici M, Maccari F, Franco E. Risk factors for psoriasis: a retrospective study on 501 outpatients clinical records. Ann Ig. 2004;16(6):753-758.
8. Murray ML, Bergstresser P, Adams-Huet B, Cohen J. Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity. Clin Exp Dermatol. 2009;34(2):140-144.
9. Sakai R, Matsui S, Fukushima M, Yasuda H, Miyauchi H, Miyachi Y. Prognostic factor analysis for plaque psoriasis. Dermatology. 2005;211(2):103-106.
10. Gelfand JM, Gladman D, Mease P, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.
11. Krueger GG. Clinical features of psoriatic arthritis. Am J Manag Care. 2002;8(6) (suppl):S160-S170.
12. Elkayam O, Ophir J, Yaron M, Caspi D. Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol. 2000;19(4):301-305. (Pubitemid 30612563)
13. Pitzalis C. Skin and joint disease in psoriatic arthritis: what is the link? Br J Rheumatol. 1998;37(5):480-483. (Pubitemid 28371845)
14. Cohen MR, Reda D, Clegg D; Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis: Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol. 1999;26(8):1752-1756.
15. Gladman DD, Antoni C, Mease P, Clegg D, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(suppl 2):ii14-ii17.
16. Libby P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am J Med. 2008;121(10)(suppl 1):S21-S31.
17. Han C, Robinson DJ Jr, Hackett M, Paramore L, Fraeman K, Bala M. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33(11):2167-2172.
18. Escalante A, Haas R, del Rincón I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med. 2005;165(14):1624-1629.
19. Herron MD, Hinckley M, Hoffman M, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol. 2005;141(12):1527-1534.
20. National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. http://www.nhlbi.nih.gov/guidelines/obesity/ob-gdlns.pdf. Accessed October 1, 2009.
21. Ciocon DH, Kimball A. Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol. 2007;157(5):850-860.
22. McGonagle D, Benjamin M, Tan A. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol. 2009;21(4):340-347.
23. Tam LS, Tomlinson B, Chu T, et al. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls: the role of inflammation. Rheumatology (Oxford). 2008;47(5):718-723.
24. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. Arch Intern Med. 2007; 167(15):1670-1675.
25. Hamminga EA, van der Lely A, Neumann H, Thio H. Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 2006;67(4):768-773. (Pubitemid 44062144)
26. Tilg H, Moschen A. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-783.
27. Lord GM, Matarese G, Howard J, Baker R, Bloom S, Lechler R. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 1998;394(6696):897-901.
28. De Rosa V, Procaccini C, Calì G, et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity. 2007;26(2):241-255.
29. Cerman AA, Bozkurt S, Sav A, Tulunay A, Elbaşi M, Ergun T. Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol. 2008; 159(4):820-826.
30. Wang Y, Chen J, Zhao Y, Geng L, Song F, Chen H. Psoriasis is associated with increased levels of serum leptin. Br J Dermatol. 2008;158(5):1134-1135.
31. Takahashi H, Tsuji H, Takahashi I, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Plasma adiponectin and leptin levels in Japanese patients with psoriasis. Br J Dermatol. 2008;159(5):1207-1208.
32. Johnston A, Arnadottir S, Gudjonsson J, et al. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol. 2008;159(2):342-350.
33. Aviña-Zubieta JA, Choi H, Sadatsafavi M, Etminan M, Esdaile J, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a metaanalysis of observational studies. Arthritis Rheum. 2008;59(12):1690-1697.
34. Gladman DD, Ang M, Su L, Tom B, Schentag C, Farewell V. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009;68(7):1131-1135.
35. Kara N, Aydin F, Senturk N, et al. Lack of association between the G-2548A polymorphism of the leptin gene and psoriasis in a Turkish population. Int J Dermatol. 2007;46(12):1271-1274.